-
KALV Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
KalVista Pharmaceuticals (KALV)
Company Profile
Quarter (USD) | Oct 24 | Jul 24 | Apr 24 | Jan 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Apr 24 | Apr 23 | Apr 22 | Apr 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 41.58 mm | 41.58 mm | 41.58 mm | 41.58 mm | 41.58 mm | 41.58 mm |
Cash burn (monthly) | (no burn) | 1.34 mm | 15.27 mm | 14.30 mm | 13.21 mm | 10.21 mm |
Cash used (since last report) | n/a | 4.01 mm | 45.66 mm | 42.77 mm | 39.51 mm | 30.53 mm |
Cash remaining | n/a | 37.57 mm | -4.08 mm | -1.19 mm | 2.07 mm | 11.05 mm |
Runway (months of cash) | n/a | 28.0 | -0.3 | -0.1 | 0.2 | 1.1 |
13F holders | Current |
---|---|
Total holders | 130 |
Opened positions | 20 |
Closed positions | 15 |
Increased positions | 48 |
Reduced positions | 32 |
13F shares | Current |
---|---|
Total value | 558.94 bn |
Total shares | 66.24 mm |
Total puts | 110.30 k |
Total calls | 501.10 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
VR Adviser | 6.25 mm | $72.37 bn |
Venrock Healthcare Capital Partners III | 4.82 mm | $0.00 |
Tang Capital Management | 4.32 mm | $50.04 bn |
Suvretta Capital Management | 4.21 mm | $48.78 bn |
Vestal Point Capital | 4.00 mm | $46.32 bn |
Frazier Life Sciences Management | 3.69 mm | $42.71 bn |
Tang Capital Partners | 3.44 mm | $50.95 mm |
Capital World Investors | 3.37 mm | $39.07 bn |
BlackRock | 3.06 mm | $35.46 bn |
Vanguard | 2.15 mm | $24.90 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Dec 24 | Benjamin L Palleiko | Common Stock | Sell | Dispose S | No | No | 9.75 | 7,627 | 74.36 k | 274,596 |
6 Dec 24 | Benjamin L Palleiko | Common Stock | Option exercise | Acquire M | No | No | 0 | 15,625 | 0.00 | 282,223 |
6 Dec 24 | Benjamin L Palleiko | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 15,625 | 0.00 | 203,126 |
26 Nov 24 | Paul K. Audhya | Common Stock | Sell | Dispose S | No | No | 9.8702 | 2,187 | 21.59 k | 97,012 |
26 Nov 24 | Christopher Yea | Common Stock | Sell | Dispose S | No | No | 9.8718 | 1,963 | 19.38 k | 91,142 |
23 Nov 24 | Laurence Reid | Stock Option Common Stock | Grant | Acquire A | No | No | 10.07 | 17,000 | 171.19 k | 17,000 |
22 Nov 24 | Paul K. Audhya | Common Stock | Option exercise | Acquire M | No | No | 0 | 5,000 | 0.00 | 99,199 |
22 Nov 24 | Paul K. Audhya | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 5,000 | 0.00 | 70,000 |
22 Nov 24 | Christopher Yea | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,125 | 0.00 | 93,105 |
22 Nov 24 | Christopher Yea | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,125 | 0.00 | 43,750 |